Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

This study has been completed.
Kyungpook National University
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd Identifier:
First received: August 8, 2013
Last updated: October 20, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)